Vor Ort
Merkzettel Warenkorb
Produktbild: Pharmacogenomic Testing in Current Clinical Practice
- 10%

Pharmacogenomic Testing in Current Clinical Practice Implementation in the Clinical Laboratory

Aus der Reihe Molecular and Translational Medicine
10% sparen

104,99 € UVP 117,69 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.04.2013

Herausgeber

Alan H. B. Wu + weitere

Verlag

Humana Press

Seitenzahl

272

Maße (L/B/H)

23,5/15,5/1,6 cm

Gewicht

441 g

Auflage

2011

Sprache

Englisch

ISBN

978-1-61779-726-2

Beschreibung

Rezension

From the reviews:

“The book is written for clinical laboratory directors ‘contemplating or assigned the task of establishing a pharmacogenomics laboratory,’ pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to … allied health practitioners, regulators, reimbursers, and test device manufacturers. … The writing is concise, clear, and accessible for what might be considered a complex topic. … Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing.” (Valerie L. Ng, Doody’s Review Service, May, 2011)

Zitat

From the reviews: "The book is written for clinical laboratory directors 'contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing." (Valerie L. Ng, Doody's Review Service, May, 2011)

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.04.2013

Herausgeber

Verlag

Humana Press

Seitenzahl

272

Maße (L/B/H)

23,5/15,5/1,6 cm

Gewicht

441 g

Auflage

2011

Sprache

Englisch

ISBN

978-1-61779-726-2

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Pharmacogenomic Testing in Current Clinical Practice
  • Part 1.        Basic concepts      
    Chapter 1.      Issues in Translation of Pharmacogenomics into Clinical Practice.
                            Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu
    Chapter 2.      Molecular Diagnostic Methods in Pharmacogenomics                        Nikolina Babic*, Loren J. Joseph, Kiang-Teck J. Yeo
    Chapter 3.      Economics of pharmacogenomic testing in clinical practice
                            Alan H.B. Wu
    Chapter 4.      From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice SystemSteven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.
     
    Part 2.        Specific pharmacogenomic targets: Chemotherapeutics
    Chapter 5.      Irinotecan
    R. Stephanie Huang, Federico Innocenti and Mark J. Ratain
    Chapter 6.      Pharmacogenomics of tamoxifen
    Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman
    Chapter 7.      Thiopurines
    Terreia S. Jones, Mary V. Relling
     
    Part 3.        Specific pharmacogenomic targets: Cardiovascular drugs
    Chapter 8.      The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs
    Charles Eby
    Chapter 9.      Clopidogrel and Salicylates
    Janice Y Chyou, Marc S Sabatine
    Chapter 10.    DNA-Guided Statin Therapy
    Gualberto Ruaño, Richard L. Seip, Jorge Duconge
    Chapter 11.    The statin response gene: Kif6
    ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.
     
    Part 4.        Drugs that cause delayed hypersensitivity
    Chapter 12.    Abacavir
    Elizabeth J. Phillips, Simon A. Mallal
    Chapter 13.    Allopurinol
    Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong ChenChapter 14.    Carbamazepine and its structurally-related antiepiletics
    Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen
    Part 5........ Miscellaneous drugs
    Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury
    Hong-Kee Lee, Lionel D. Lewis
    Chapter 16.    Immunosuppressants Pharmacogenomics
                            Ping Wang

    Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.
     
    Part 2.        Specific pharmacogenomic targets: Chemotherapeutics
    Chapter 5.      Irinotecan
    R. Stephanie Huang, Federico Innocenti and Mark J. Ratain
    Chapter 6.      Pharmacogenomics of tamoxifen
    Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman
    Chapter 7.      Thiopurines
    Terreia S. Jones, Mary V. Relling
     
    Part 3.        Specific pharmacogenomic targets: Cardiovascular drugs
    Chapter 8.      The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs
    Charles Eby
    Chapter 9.      Clopidogrel and Salicylates
    Janice Y Chyou, Marc S Sabatine
    Chapter 10.    DNA-Guided Statin Therapy
    Gualberto Ruaño, Richard L. Seip, Jorge Duconge
    Chapter 11.    The statin response gene: Kif6
    ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.
     
    Part 4.        Drugs that cause delayed hypersensitivity
    Chapter 12.    Abacavir
    Elizabeth J. Phillips, Simon A. Mallal
    Chapter 13.    Allopurinol
    Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong ChenChapter 14.    Carbamazepine and its structurally-related antiepiletics
    Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen
    Part 5........ Miscellaneous drugs
    Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury
    Hong-Kee Lee, Lionel D. Lewis
    Chapter 16.    Immunosuppressants Pharmacogenomics
                            Ping Wang

    Chapter 14.    Carbamazepine and its structurally-related antiepiletics
    Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen
    Part 5........ Miscellaneous drugs
    Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury
    Hong-Kee Lee, Lionel D. Lewis
    Chapter 16.    Immunosuppressants Pharmacogenomics
                            Ping Wang